1. Introduction {#sec1}
===============

Acute necrotising retinitis presents as multifocal, well-demarcated areas of retinal necrosis of retina with rapid, circumferential progression of necrosis with occlusive vasculitis accompanied with vitritis. Varicella-zoster virus or herpes simplex virus type (HSV) 1 have been found to cause ARN in middle aged patients. Herpes simplex virus type 2 has been implicated to causes acute retinal necrosis in patients younger than 20 years.[@bib1] Acute retinal necrosis is a rare presenting feature of CMV retinitis.[@bib2]^,^[@bib3]

In retinopathy of prematurity (ROP) stage 3 plus disease in zone 1 at post menstrual age (PMA) of 39 weeks is an indication for treatment. It is unlikely for peripheral lasered retina to develop vascularity in 4 weeks. In CMV retinitis, retinal vascular endothelial cells are the initial target in the development of viral retinitis and subsequently infection spreads to perivascular glia, müller cells and retinal pigment epithelium.[@bib4] The mode of entry of CMV into endothelial and RPE cells in vivo has been demonstrated via endocytosis.

Retinitis with other systemic condition in a premature infant has been reported earlier.[@bib5]^,^[@bib6] Co-existing ARN with ROP has been reported earlier but in both the cases the causative organism was herpes simplex virus 2.[@bib7] We are reporting a case of bilateral acute necrotising retinitisin an infant due to CMV infection.

2. Case report {#sec2}
==============

A former 26 week gestational age, 1000 g preterm second born twin infant was evaluated at a tertiary level neonatal intensive care unit (NICU) on 34th day of life (PMA: 34weeks) for ROP. On dilated fundus examination large avascular retina in zone 1 was present and infant was subsequently followed up. The infant had been previously treated for respiratory distress syndrome, patent ductus arteriosus and had underwent multiple blood transfusion for anemia of prematurity and had been discharged from NICU.

The infant had been previously being discharged from NICU after treatment for respiratory distress syndrome, patent ductus arteriosus and had underwent multiple blood transfusion for anemia of prematurity. The patient during the hospital stay had persistent anemia and thrombocytopenia for which blood transfusion was given. Persisting thrombocytopenia led to a suspicion of TORCH infection. The titres of serum CMV IgM (2.39 by CMIA) and IgG (151.65 au/ml by CMIA) were found to be reactive and CMV DNA (\>57.1 copies/ml) was detected in urine (real time PCR). The titres for toxoplasma, rubella, HSV 1 and HSV2 was negative. The baby was screened for CMV retinitis at PMA of 35 weeks but no lesion was detected. The infant was managed with supportive measures.

On follow up visit at PMA: 39 weeks bilateral ROP stage 3 plus disease in zone 1 was present along with popcorn lesions on dilated fundus examination ([Fig. 1](#fig1){ref-type="fig"}). The ROP was treated with fluorescein angiography (FA) guided laser.Fig. 1a and b: Fundus photo at 39 weeks of age revealed stage 3 retinopathy of prematurity with popcorn lesions in zone 1 in right and left eye respectively. 1c and d: Fundus fluorescein angiography revealing peripheral avascular retina with leakage depicting neovascularisation in right and left eye respectively.Fig. 1

The ROP along with popcorn lesions started to regress with time. After 1 month of laser treatment of ROP (PMA: 42 weeks), there was vitreous haze due to vitritis, inferior vitreous condensation and new white lesions in lower nasal periphery with white fluffy haemorrhagic patch ([Fig. 2](#fig2){ref-type="fig"}, [Fig. 3](#fig3){ref-type="fig"}). In the light of these new findings the lesions were suspected to have peripheral retinal necrosis due to infective pathology.The fundus findings resembled necrotising retinitis. As the infant was seropositive for CMV earlier, necrotising retinitis due to CMV was suspected. The CMV DNA was repeated and was detected in serum. The infant was started on oral valganciclovir therapy (55mg, 5 ml per day) for 4 weeks.Fig. 2Fundus photo of right eye at 2 months 2 weeks of corrected age showing media haze due to vitritis, vitreous condensation (black arrow) and necrotic retina with hemorrhage (red arrow) in inferotemporal and inferonasal quadrant. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 2Fig. 3Fundus photo of left eye at 2 months 2 weeks of corrected age revealed media haze due to vitritis, vitreous condensation (black arrow) and necrotic retina with hemorrhage (red arrow) in inferotemporal and inferonasal quadrant. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 3

After 2 weeks of completion of antiviral treatment (PMA 44 weeks), the dilated fundus examination revealed healing lesions in left eye. In the right eye, inferior and temporal lesions were healing as suggested by decreased size. At 4 weeks of completion of antiviral treatment (PMA 46 weeks) fundus examination revealed healed retinitis in both eyes ([Fig. 4](#fig4){ref-type="fig"}). The dose of valganciclovir was tapered to 3.5 ml BD for 2 weeks The CMV DNA was repeated and titres were found to be insignificant. Thereafter the treatment was stopped. On last follow up the patient had resolved lesions and vision was appropriate for age.Fig. 4Fundus photo of both eyes showing healed retinitis lesions along with healed laser spots.Fig. 4

3. Discussion {#sec3}
=============

Bilateral necrotising retinitis is a rare presenting feature of CMV. There has been report of coexistent ARN with ROP in a premature infant but CMV has not been implicated as an etiology so far.[@bib8]

The infant was treated for ROP at PMA of 39 weeks for stage 3 plus disease in zone 1 according to standard protocol and avascular retina was lasered. The development of vitritis, inferior vitreous condensation and new white lesions in lower nasal periphery with white fluffy haemorrhagic patch after 1 month of laser treatment could either be acute retinal necrosis, or necrotic changes secondary to laser or CMV. The absence of neovascularisation, recrudesce of existing vessel and existing vitritis were indicative of inflammation. The peripheral lasered retina developing CMV retinitis was intriguing as CMV has more predilection for retinal endothelial cells.A hypothesis regarding mechanism of CMV retinitis states that CMV gains entry into the retina through retinal vascular endothelial cells. This is followed by spread to deeper layers of the retina. Dislodgement of infected endothelial cells leads to distal spread of CMV retinitis.[@bib9] It was unlikely that the lasered retina was vascularized after laser treatment within a month. The presence of vitritis, inferior vitreous condensation, peripheral areas of retinal necrosis were features suggestive of ARN. Therefore, the diagnosis of necrotising retinitis due to CMV was made based on positive seropositivity and clinical picture.

Valgancyclovir as therapy for CMV infection in an infant is debated The first episode of CMV infection was managed conservatively. Oral valganciclovir was instituted inview of the acute necrotising retinitis and aggressive disease course. Vision could have been affected if treatment was delayed.

Early diagnosis and appropriate management resulted in resolution of retinitis. Therefore, a high degree of suspicion is needed to diagnose acute necrotising retinitis due to CMV in an infant.
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